Induction of apoptosis and cellular senescence in mice lacking transcription elongation factor, Elongin A

Cell Death and Differentiation

Volumn 14, Issue 4, 2007, Pages 716-726

  Miyata, K ^a   Yasukawa, T ^a   Fukuda, M ^b   Takeuchi, T ^a   Yamazaki, K ^b,c,d   Sakumi, K ^c   Tamamori Adachi, M ^b   Ohnishi, Y ^c   Ohtsuki, Y ^a   Nakabeppu, Y ^c   Kitajima, S ^b   Onishi, S ^a   Aso, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Microbial Chemistry Research Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGIN; ELONGIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL AGING; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENETIC TRANSCRIPTION; GROWTH RETARDATION; HOMOZYGOSITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL AGING; FEMALE; FETAL DEATH; FETUS; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ELONGATION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 33947407292     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402067     Document Type: Article

References (39)

1. Roeder RG. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem Sci 1996; 21: 327-335.
2. Conaway JW, Shilatifard A, Dvir A, Conaway RC. Control of elongation by RNA polymerase II. Trends Biochem Sci 2000; 25: 375-380.
3. Shilatifard A, Conaway RC, Conaway JW. The RNA polymerase II elongation complex. Annu Rev Biochem 2003; 72: 693-715.
4. Sims III RJ, Belotserkovskaya R, Reinberg D. Elongation by RNA polymerase II: The short and long of it. Genes Dev 2004; 18: 2437-2468.
5. Wind M, Reines D. Transcription elongation factor SII. BioEssays 2000; 22: 327-336.
6. Price DH, Sluder AE, Greenleaf AL. Dynamic interaction between a Drosophila transcription factor and RNA polymerase II. Mol Cell Biol 1989; 9: 1465-1475.
7. Bradsher JN, Jackson KW, Conaway RC, Conaway JW. RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. J Biol Chem 1993; 268: 25587-25593.
8. Aso T, Lane WS, Conaway JW, Conaway RC. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II. Science 1995; 269: 1439-1443.
9. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 1996; 271: 1873-1876.
10. Selby CP, Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc Natl Acad Sci USA 1997; 94: 11205-11209.
11. Garrett KP, Tan S, Bradsher JN, Lane WS, Conaway JW, Conaway RC. Molecular cloning of an essential subunit of RNA polymerase II elongation factor SIII. Proc Natl Acad Sci USA 1994; 91: 5237-5241.
12. Garrett KP, Aso T, Bradsher JN, Foundling SI, Lane WS, Conaway RC et al. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc Natl Acad Sci USA 1995; 92: 7172-7176.
13. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995; 269: 1402-1406.
14. Aso T, Haque D, Barstead RJ, Conaway RC, Conaway JW. The inducible elongin A elongation activation domain: Structure, function and interaction with the elongin BC complex. EMBO J 1996; 15: 5557-5566.
15. Gerber M, Eissenberg JC, Kong S, Tenney K, Conaway JW, Conaway RC et al. In vivo requirement of the RNA polymerase II elongation factor Elongin A for proper gene expression and development. Mol Cell Biol 2004; 24: 9911-9919.
16. Gerber M, Tenney K, Conaway JW, Conaway RC, Eissenberg JC, Shilatifard A. Regulation of heat shock gene expression by RNA polymerase II elongation factor, Elongin A. J Biol Chem 2005; 280: 4017-4020.
17. Robertson EJ In: Robertson EJ (ed). Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. IRL Press: Oxford, 1987.
18. Yamazaki K, Aso T, Ohnishi Y, Ohno M, Tamura K, Shuin T et al. Mammalian Elongin A is not essential for cell viability but is required for proper cell cycle progression with limited alteration of gene expression. J Biol Chem 2003; 278: 13585-13589.
19. Aso T, Amimoto K, Takebayashi S, Okumura K, Hatakeyama M. Structural organization and chromosome location of the mouse Elongin A gene (Tceb3). Cytogenet Cell Genet 1999; 86: 259-262.
20. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367.
21. Semenza GL, Agani F, Iyer N, Kotch L, Laughner E, Leung S et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann NY Acad Sci 1999; 874: 262-268.
22. Harris AL. Hypoxia-A key regulatory factor in tumor growth. Nat Rev Cancer 2001; 2: 38-47.
23. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10: 995-1005.
24. Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson II RS et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 2004; 279: 48930-48940.
25. Hammond EM, Giaccia AJ. The role of p53 in hypoxia-induced apoptosis. Biochem Biophys Res Commun 2005; 331: 718-725.
26. Ljungman M, O'Hagan HM, Paulsen MT. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation. Oncogene 2001; 20: 5964-5971.
27. Ben-Porath I, Weinberg RA. When cells get stressed: An integrative view of cellular senescence. J Clin Invest 2004; 113: 8-13.
28. Han EKH, Ng SC, Arber N, Begemann M, Weinstein IB. Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis. Apoptosis 1999; 4: 213-219.
29. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/ 6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22: 3389-3403.
30. Iwasa H, Han J, Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003; 8: 131-144.
31. Nebreda AR, Porras A. p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 2000; 25: 257-260.
32. Murphy PJM, Galigniana MD, Morishima Y, Harrell JM, Kwok RPS, Ljungman M et al. Pifithrin-α inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J Biol Chem 2004; 279: 30195-30201.
33. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003; 34: 263-264.
34. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 2000; 14: 34-44.
35. Mizukami Y, Li J, Zhang X, Zimmer MA, Iliopoulos O, Chung DC. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res 2004; 64: 1765-1772.
36. Leonard MO, Cottell DC, Godson C, Brady HR, Taylor CT. The role of HIF-1α in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem 2003; 278: 40296-40304.
37. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K et al. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 2001; 8: 367-376.
38. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002; 22: 2283-2293.
39. Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 1993; 8: 3313-3322.